TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in TScan Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 81
- −11 vs. Q1 2025
- Shares held
- 35.7M
- −4.41M (−11.0%) vs. Q1 2025
- Total value
- $51.8M
- −$3.57M (−6.4%) vs. Q1 2025
- New holders
- 21
- 26 more added
- Sold out
- 32
- 18 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $35.1M |
| Q1 2026 | 60 | $32.8M |
| Q4 2025 | 61 | $30.7M |
| Q3 2025 | 73 | $62.9M |
| Q2 2025 | 81 | $51.8M |
| Q1 2025 | 92 | $55.4M |
| Q4 2024 | 89 | $126.2M |
| Q3 2024 | 89 | $208.3M |
| Q2 2024 | 81 | $242.6M |
| Q1 2024 | 66 | $272.3M |
| Q4 2023 | 54 | $186.1M |
| Q3 2023 | 32 | $73.2M |
| Q2 2023 | 28 | $69.9M |
| Q1 2023 | 28 | $20.3M |
| Q4 2022 | 28 | $14.8M |
| Q3 2022 | 26 | $29.0M |
| Q2 2022 | 24 | $30.4M |
| Q1 2022 | 25 | $26.3M |
| Q4 2021 | 29 | $44.4M |
| Q3 2021 | 27 | $83.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding TScan Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,626−100.0% | Sold out |
| Police & Firemen's Retirement System of New Jersey | 0 | $0 | 0.00% | −7,720−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −6,169−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −3,937−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −3,762−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −2,782−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,329−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −555−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −492−100.0% | Sold out |
| Sterling Capital Management LLC | 0 | $0 | 0.00% | −259−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −166−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −7−100.0% | Sold out |